Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
about
Adenocarcinoma of the urinary bladderThe expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder.Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma.Expression of cadherin 17 in well-differentiated neuroendocrine tumours.Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder.Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall.Young investigator challenge: Cadherin-17 and SATB2 in cytology specimens: Do these new immunostains help in differentiating metastatic colorectal adenocarcinoma from adenocarcinomas of other origins?Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.
P2860
Q26796705-3E6760C1-0F80-4EE8-8786-969016E05470Q35154167-7B1DFB27-C02B-4541-990B-1D33CA277089Q36382681-80140EAA-85FE-4FF9-A160-CC838E7909FEQ39129339-32572949-07D3-4A5F-B601-6A39FA4BD9AEQ40435708-712E93E5-C6F5-4924-B124-1601F32A063FQ42362674-6DD45F3B-8113-43DF-8A7A-996A7973896DQ45901176-D39BC81B-DD95-45E3-B208-EDEED91C7CE5Q47283558-39838BCC-441F-4970-976C-A10027A3CE98Q53242925-A0B5943F-88F3-4224-AE1E-8248340927DEQ55113382-12BB655F-F1D7-493D-8739-3C68A5FAED65Q55251613-34727C2D-39DA-46CD-A54F-2A6FED3B3BBC
P2860
Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Distinguishing primary adenoca ...... les emphasizing novel markers.
@en
Distinguishing primary adenoca ...... les emphasizing novel markers.
@nl
type
label
Distinguishing primary adenoca ...... les emphasizing novel markers.
@en
Distinguishing primary adenoca ...... les emphasizing novel markers.
@nl
prefLabel
Distinguishing primary adenoca ...... les emphasizing novel markers.
@en
Distinguishing primary adenoca ...... les emphasizing novel markers.
@nl
P2093
P2860
P1433
P1476
Distinguishing primary adenoca ...... les emphasizing novel markers.
@en
P2093
Antonio Lopez-Beltran
David J Grignon
John N Eble
Lee Ann Baldridge
Liang Cheng
Michael O Koch
Muhammad T Idrees
Robert E Emerson
Shaobo Zhang
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.229
P577
2013-01-25T00:00:00Z